Stephen Greene

Mar 25, 2024 | jacc.org | Stephen Greene |Iyanuoluwa Ayodele |Jacob Pierce |Muhammad Khan

ABSTRACTBackgroundUS nationwide estimates of the proportion of patients newly diagnosed with heart failure with reduced ejection fraction (HFrEF) eligible for quadruple medical therapy, and the associated benefits of rapid implementation, are not well characterized. ObjectivesThis study sought to characterize the degree to which patients newly diagnosed with HFrEF are eligible for quadruple medical therapy, and the projected benefits of in-hospital initiation.

Oct 8, 2023 | hcplive.com | Muthiah Vaduganathan |Stephen Greene

The largest annual heart failure-specific meeting in the US, the Heart Failure Society of America (HFSA) Annual Scientific Meeting serves as a showcase for the latest innovations, advancements, and revelations, not only for advanced heart failure and transplant specialists, but the continuum of the care team. There may be no better example of this than the meeting’s sessions dedicated to late-breaking clinical trials.

Apr 5, 2023 | jacc.org | Stephen Greene |Johann Bauersachs |Jasper J. Brugts |Justin A. Ezekowitz

JACC Journals › JACC › Archives › Vol. 82 No. 6 AbstractDespite worsening heart failure (HF) being extremely common, expensive, and associated with substantial risk of death, there remain no dedicated clinical practice guidelines for the specific management of these patients. The lack of a management guideline is despite a rapidly evolving evidence-base, as a number of recent clinical trials have demonstrated multiple therapies to be safe and efficacious in this high-risk population.

Mar 14, 2023 | onlinejcf.com | Izza Shahid |Gregg C. Fonarow |Stephen Greene

The prevalence of heart failure (HF) continues to steadily rise and now more than 64 million people globally carry the diagnosis. 1 Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.